With a population of just over 10.6 million, the Czech Republic offers excellent recruitment potential due to its large population of modern treatment-naïve patients in a wide range of therapeutic areas.
It is recognized as an attractive location for international clinical trials with a strong track record for producing high-quality data and lengthy experience in Good Clinical Practices provided by the ICH-GCP
The Czech Republic is the second largest pharma market in Central and Eastern Europe – valued at €2.95 billion in 2019.This pharma market has demonstrated strong growth in recent years in the innovative drug market - €1.6 billion in 2021.
Its regulatory authority the State Institute for Drug Control (SUKL) has a reputation for being open, efficient, and supportive in its approach to supporting clinical research. This allows for quick approval periods and expedited start-up timelines (on average 60 days).
The country has a Universal Healthcare System conducive to patient enrollment. In addition, it boasts a large network of public hospitals and clinics as well as specialized centres for patients with specific diagnoses.
The country has a large pool of highly educated and skilled medical professionals with 10 medical faculties in 6 universities including the internationally renowned Institute of Clinical and Experimental Medicine (IKEM) in Prague and Masaryk Memorial Cancer Institute (MMCI) in Brno.
An EU member since 2004, its clinical trial regulatory and legislative framework is harmonized with EU directives in relation to clinical research.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.